These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9849497)

  • 1. Severe anaphylactic reactions to oxaliplatin.
    Tournigand C; Maindrault-Goebel F; Louvet C; de Gramont A; Krulik M
    Eur J Cancer; 1998 Jul; 34(8):1297-8. PubMed ID: 9849497
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylaxis produced by oxaliplatin.
    González-Mahave I; Lobera Iabairu T; Blasco Sarramián A; del Pozo Gil MD; Zorrilla M; Vélez de Mendizábal E
    J Investig Allergol Clin Immunol; 2005; 15(1):75-7. PubMed ID: 15864887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin-induced proximal renal tubular acidosis.
    Negro A; Grasselli C; Galli P
    Intern Emerg Med; 2010 Jun; 5(3):267-8. PubMed ID: 19937480
    [No Abstract]   [Full Text] [Related]  

  • 4. A case report of oxaliplatin extravasation.
    Foo KF; Michael M; Toner G; Zalcberg J
    Ann Oncol; 2003 Jun; 14(6):961-2. PubMed ID: 12796037
    [No Abstract]   [Full Text] [Related]  

  • 5. Anaphylactic reaction to oxaliplatin: a case report.
    Larzillière I; Brandissou S; Breton P; Lingoungou A; Gargot D; Ramain JP; Harnois C
    Am J Gastroenterol; 1999 Nov; 94(11):3387-8. PubMed ID: 10566767
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anaphylactic reaction to oxaliplatin--a case of colon cancer].
    Sagawa T; Sato Y; Abe S; Okuda T; Araki N; Takahari D; Okamoto T; Takayama T; Kato J; Niitsu Y
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2093-6. PubMed ID: 17197761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Bhargava P; Gammon D; McCormick MJ
    Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
    [No Abstract]   [Full Text] [Related]  

  • 8. [Readministration of oxaliplatin using a rapid desensitization method after severe anaphylactic reaction].
    Arotçarena R; Berthélémy P; Piot M; Pariente A
    Gastroenterol Clin Biol; 2001 Feb; 25(2):206-7. PubMed ID: 11319450
    [No Abstract]   [Full Text] [Related]  

  • 9. Interstitial lung disease associated with oxaliplatin: description of two cases.
    Pena Alvarez C; Suh Oh HJ; Sáenz de Miera Rodríguez A; García Arroyo FR; Covela Rúa M; Salgado Boquete L; López Clemente PM; Constenla Figueiras M
    Clin Transl Oncol; 2009 May; 11(5):332-3. PubMed ID: 19451069
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohemolytic anemia following oxaliplatin administration.
    Garufi C; Vaglio S; Brienza S; Conti L; D'Attino RM; Girelli G; Terzoli E
    Ann Oncol; 2000 Apr; 11(4):497. PubMed ID: 10847475
    [No Abstract]   [Full Text] [Related]  

  • 12. Sudden-onset thrombocytopenia with oxaliplatin.
    Dold FG; Mitchell EP
    Ann Intern Med; 2003 Jul; 139(2):E156. PubMed ID: 12859182
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute idiopathic polyneuritis: a potentially fatal neuropathy that is difficult to diagnose in patients receiving oxaliplatin].
    Trabut JB; Brezault C; Chaussade S; Lamarque D
    Gastroenterol Clin Biol; 2007 Feb; 31(2):198-9. PubMed ID: 17347631
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiation recall with oxaliplatin: report of a case and a review of the literature.
    Chan RT; Au GK; Ho JW; Chu KW
    Clin Oncol (R Coll Radiol); 2001; 13(1):55-7. PubMed ID: 11292139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis after oxaliplatin.
    Médioni J; Coulon MA; Morere JF; Hennebelle F; Piperno-Neumann S; Breau JL
    Ann Oncol; 1999 May; 10(5):610. PubMed ID: 10416017
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genetic backgrounds of peripheral neuropathy induced by oxaliplatin].
    Mitsuma A; Ando Y
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):62-5. PubMed ID: 23391543
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication.
    Lee MY; Yang MH; Liu JH; Yen CC; Lin PC; Teng HW; Wang WS; Chiou TJ; Chen PM
    Support Care Cancer; 2007 Jan; 15(1):89-93. PubMed ID: 16865410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute, generalised but transient muscle cramping and weakness shortly after first oxaliplatin infusion.
    Krexner E; Stickler A; Prainer C; Finsterer J
    Med Oncol; 2012 Dec; 29(5):3592-3. PubMed ID: 22669568
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution.
    Lenz G; Hacker UT; Kern W; Schalhorn A; Hiddemann W
    Anticancer Drugs; 2003 Oct; 14(9):731-3. PubMed ID: 14551506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
    Atkins CD
    J Clin Oncol; 2014 Oct; 32(29):3341. PubMed ID: 25135996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.